Fu J, Liang C, Sun L, Zhao H, Cui Z, Lang J
World J Surg Oncol. 2025; 23(1):87.
PMID: 40087731
DOI: 10.1186/s12957-025-03739-9.
Peng Y, Yang J, Ao J, Li Y, Shen J, He X
Elife. 2025; 13.
PMID: 40066698
PMC: 11896611.
DOI: 10.7554/eLife.97335.
de Miranda L, Uzabakiriho B, Louw M, Ngene N
Int Med Case Rep J. 2025; 18:281-287.
PMID: 40052087
PMC: 11883410.
DOI: 10.2147/IMCRJ.S500905.
Wu C, Lv X, Wang F, Xu Q, Lou H, Zhang X
BMC Cancer. 2025; 25(1):364.
PMID: 40016665
PMC: 11869410.
DOI: 10.1186/s12885-024-13282-7.
Zhang J, Liu X, Huang Y, Kong L, Su M, Hu Z
3D Print Med. 2025; 11(1):7.
PMID: 40009089
PMC: 11863587.
DOI: 10.1186/s41205-025-00256-z.
The Role of Lymphocyte Recovery Index in Prognosis Prediction for Locally Advanced Cervical Cancer With Radiation-Induced Lymphopenia.
Li Y, Liu A, Wang X, Guo L, Li Y, Liu D
Cancer Med. 2025; 14(4):e70638.
PMID: 39950796
PMC: 11827101.
DOI: 10.1002/cam4.70638.
Spectral computed tomography in the assessment of metastatic lymph nodes in cervical cancer patients treated with definitive radiotherapy: a single-center, prospective study.
Zeng Z, Chen Y, Sun Y, Zhou B, Xu H, He L
Clin Exp Metastasis. 2025; 42(2):15.
PMID: 39907854
DOI: 10.1007/s10585-025-10330-9.
[F]FDG PET/CT Radiomics in Cervical Cancer: A Systematic Review.
Hotton J, Beddok A, Moubtakir A, Papathanassiou D, Morland D
Diagnostics (Basel). 2025; 15(1.
PMID: 39795593
PMC: 11720459.
DOI: 10.3390/diagnostics15010065.
Treatment advances across the cervical cancer spectrum.
Francoeur A, Monk B, Tewari K
Nat Rev Clin Oncol. 2025; 22(3):182-199.
PMID: 39753753
DOI: 10.1038/s41571-024-00977-w.
Addition of Bevacizumab to Chemotherapy and Its Impact on Clinical Efficacy in Cervical Cancer: A Systematic Review and Meta-Analysis.
Shahzad A, Ur Rehman A, Naz T, Rasool M, Saeed A, Rasheed S
Pharmacy (Basel). 2024; 12(6).
PMID: 39728845
PMC: 11677453.
DOI: 10.3390/pharmacy12060180.
Nanotheranostics for gynecological cancers: a path forward for Africa.
Aza M, Suberu A, Balogun M, Adegbola G, Sankoh M, Oyediran T
Med Oncol. 2024; 42(1):34.
PMID: 39704911
DOI: 10.1007/s12032-024-02582-4.
Risk Factor Analysis and Prediction of Para-Aortic Lymph Node Metastases in Locally Advanced Cervical Cancer.
Wang T, Wei J, Jiang L, Huang L, Huang T, Ma S
Cancer Med. 2024; 13(24):e70492.
PMID: 39679762
PMC: 11647704.
DOI: 10.1002/cam4.70492.
Limited diagnostic performance of imaging evaluation for staging in gastric-type endocervical adenocarcinoma: a multi-center study.
Himoto Y, Kido A, Yamanoi K, Kurata Y, Morita S, Kikkawa N
Jpn J Radiol. 2024; .
PMID: 39625593
DOI: 10.1007/s11604-024-01713-1.
Endocervical adenocarcinoma with a micropapillary component: a clinicopathologic analysis in the setting of current WHO classification.
Liu K, Shi H, Gao L, Ye L, Lu B
Virchows Arch. 2024; .
PMID: 39579262
DOI: 10.1007/s00428-024-03971-w.
Establishment of a Novel Risk Stratification System Integrating Clinical and Pathological Parameters for Prognostication and Clinical Decision-Making in Early-Stage Cervical Cancer.
Wu H, Huang L, Chen X, Ouyang Y, Li J, Chen K
Cancer Med. 2024; 13(22):e70394.
PMID: 39555813
PMC: 11571237.
DOI: 10.1002/cam4.70394.
SwinUNeCCt: bidirectional hash-based agent transformer for cervical cancer MRI image multi-task learning.
Yang C, Tan Z, Wang Y, Bi R, Shi T, Yang J
Sci Rep. 2024; 14(1):24621.
PMID: 39427015
PMC: 11490486.
DOI: 10.1038/s41598-024-75544-5.
Efficacy and safety of pembrolizumab in cervical cancer: Protocol for systematic review and meta-analysis of randomized clinical trials.
Dantas D, de Souza A, de Araujo Santos Camargo J, Costa A, Samento A, Pereira de Santana Gomes A
PLoS One. 2024; 19(10):e0312004.
PMID: 39388448
PMC: 11466423.
DOI: 10.1371/journal.pone.0312004.
Parasites revive hope for cancer therapy.
Eissa M, Salem A, El Skhawy N
Eur J Med Res. 2024; 29(1):489.
PMID: 39367471
PMC: 11453045.
DOI: 10.1186/s40001-024-02057-2.
Para-aortic and pelvic lymphadenectomy in locally advanced cervical cancer with pelvic lymph node metastasis.
Jiang W, Zhong M, Wang S, Chen Y, Wang Y, Zeng S
World J Surg Oncol. 2024; 22(1):262.
PMID: 39350212
PMC: 11440892.
DOI: 10.1186/s12957-024-03540-0.
Validation and usability of SeDAR e-health video for enhancing cervical cancer screening.
Romli R, Mohamad E, Rahman R, Chew K, Hashim S, Mohammed Nawi A
PLoS One. 2024; 19(9):e0310555.
PMID: 39288121
PMC: 11407639.
DOI: 10.1371/journal.pone.0310555.